Who are the top shareholders of the Nukleus Office?

The top shareholder of Nukleus Office is Puja Gupta, holding 45.29%, with no pledged promoter holdings. The highest public shareholder is Anshul Aggarwal at 4.3%, and there are no mutual funds or foreign institutional investors involved.

The top shareholders of Nukleus Office include the promoters, with Puja Gupta holding the highest stake at 45.29%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) involved. The highest public shareholder is Anshul Aggarwal, who holds 4.3%. Individual investors also have holdings, but specific details on those are not provided.

Has Nukleus Office declared dividend?

No Dividend History Available

Who are the peers of the Nukleus Office?

Nukleus Office's peers include Future Market, Dynavision, Evans Electric, Mangal Compuso., Phoenix Intl., Parle Industries, SVC Industries, and Happy Square. Future Market has the highest 1-year return at 148.89%, while Dynavision has the lowest at -5.13%, and Nukleus Office's return is unavailable for comparison.

Peers: The peers of the Nukleus Office are Future Market, Dynavision, Evans Electric, Mangal Compuso., Phoenix Intl., Parle Industries, SVC Industries, and Happy Square.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dynavision and Evans Electric, while Average management risk is found at Evans Electric and the rest. Below Average management risk is noted at Future Market, Mangal Compuso., Phoenix Intl., Nukleus Office, Parle Industries, and SVC Industries. Growth is Excellent at Evans Electric, Good at Future Market, Dynavision, and Mangal Compuso., and Below Average at Phoenix Intl., Nukleus Office, Parle Industries, and SVC Industries. Capital Structure is Good at Dynavision and Evans Electric, while Below Average is seen at Future Market, Mangal Compuso., Phoenix Intl., Nukleus Office, Parle Industries, SVC Industries, and Happy Square.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Future Market at 148.89%, while the peer with the lowest is Dynavision at -5.13%. Nukleus Office's 1-year return is not available for comparison. Additionally, the six-month return is negative for Future Market, Dynavision, Phoenix Intl., Parle Industries, SVC Industries, and Happy Square.

What does Nukleus Office do?

Nukleus Office Solutions Ltd is a micro-cap company in the diversified commercial services industry, incorporated in 2019 and converted to a public limited company in 2024. It currently reports no sales or profits, with a market cap of INR 66 Cr.

Overview: <BR>Nukleus Office Solutions Ltd operates in the diversified commercial services industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Nukleus Office Solutions Ltd was originally incorporated as "Nukleus Office Solutions Private Limited" in 2019. The company later converted its status to a public limited company and changed its name to "Nukleus Office Solutions Limited" on July 29, 2024. There is no sales or profit data reported for any quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 66 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 32.00 <BR>Industry P/E: 32 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price-to-Book: 0.00 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Nukleus Office?

As of 24th July, Nukleus Office Solutions Ltd has a market capitalization of 69.00 Cr, classified as a Micro Cap, with no valid data available for recent net sales, net profit, shareholder's funds, or total assets.

As of 24th July, <BR><BR>Market Cap: Nukleus Office Solutions Ltd has a market capitalization of 69.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: There is no valid data available for the latest annual period regarding Shareholder's Funds and Total Assets.

Is Nukleus Office overvalued or undervalued?

As of September 29, 2025, Nukleus Office is considered undervalued with a valuation grade upgrade to attractive, featuring a PE Ratio of 31.32, an EV to EBITDA of 7.86, and a ROCE of 13.65%, making it more favorably valued compared to peers like Altius Telecom and Embassy Office REIT, despite a recent 1-week return of -1.23%.

As of 29 September 2025, the valuation grade for Nukleus Office has moved from fair to attractive, indicating a positive shift in its market perception. The company is currently deemed undervalued based on its financial metrics. Key ratios include a PE Ratio of 31.32, an EV to EBITDA of 7.86, and a ROCE of 13.65%. <BR><BR>In comparison to its peers, Nukleus Office's PE Ratio is significantly lower than Altius Telecom's 54.74, which is classified as very attractive, while Embassy Office REIT, considered very expensive, has a PE Ratio of 24.58. This suggests that Nukleus Office presents a more favorable valuation relative to its peers. Notably, the stock has shown resilience with a 1-week return of -1.23% compared to a -2.18% return for the Sensex, reinforcing its attractiveness in the current market environment.

When is the next results date for Nukleus Office?

The next results date for Nukleus Office is 11 November 2025.

The next results date for Nukleus Office is scheduled for 11 November 2025.

How has been the historical performance of Nukleus Office?

Nukleus Office experienced significant growth from March 2024 to March 2025, with net sales increasing from 17.13 Cr to 28.71 Cr and profit after tax rising from 1.20 Cr to 2.06 Cr. Key metrics such as operating profit margin and earnings per share also improved, indicating a strong upward trend in financial performance.

Answer:<BR>The historical performance of Nukleus Office shows significant growth from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the standalone annual results, Nukleus Office reported net sales of 28.71 Cr in March 2025, a substantial increase from 17.13 Cr in March 2024. The total operating income mirrored this growth, rising to 28.71 Cr from 17.13 Cr. Total expenditure also increased, reaching 22.20 Cr in March 2025 compared to 13.89 Cr in the previous year. Consequently, the operating profit (PBDIT) rose to 6.65 Cr from 3.28 Cr, with a notable operating profit margin of 22.68% in March 2025, up from 18.91%. Profit before tax improved to 2.74 Cr from 1.60 Cr, leading to a profit after tax of 2.06 Cr, compared to 1.20 Cr in March 2024. The earnings per share (EPS) increased to 5.11 from 4.76, while the book value per share surged to 97.4 from 16.66. On the balance sheet, total assets grew to 58.84 Cr from 19.08 Cr, and total liabilities rose to 58.84 Cr from 19.08 Cr. The cash flow from financing activities saw a significant increase to 34.00 Cr in March 2025 from 8.00 Cr in March 2024, contributing to a net cash inflow of 18.00 Cr, up from 5.00 Cr. Overall, these metrics reflect a robust upward trend in the financial performance of Nukleus Office.

Which are the latest news on Nukleus Office?

Why is Nukleus Office falling/rising?

As of 04-Dec, the stock price of Nukleus Office Solutions Ltd is stable at 180.00, having risen 2.86% over the past week while underperforming its sector today. Despite a generally bullish trend indicated by moving averages, declining trading volume and erratic trading patterns suggest a cautious outlook for the stock.

As of 04-Dec, the stock price of Nukleus Office Solutions Ltd is currently at 180.00, with no change from the previous trading session. Despite this stability in price, the stock has shown a positive performance over the past week, rising by 2.86%, while the benchmark Sensex has declined by 0.53%. This indicates that Nukleus Office is outperforming the market in the short term.<BR><BR>However, the stock has underperformed its sector today by 0.4%, suggesting that while it has been rising recently, it is not keeping pace with its peers on this particular day. Additionally, there has been erratic trading, as the stock did not trade on 2 out of the last 20 days, which may contribute to uncertainty among investors.<BR><BR>Moreover, the delivery volume has significantly decreased, with a drop of 66.67% compared to the 5-day average, indicating falling investor participation. This decline in trading activity could signal a lack of confidence or interest from investors, which may hinder any potential upward momentum.<BR><BR>On a positive note, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a generally bullish trend over the longer term. However, the liquidity remains adequate for trading, as it is based on 2% of the 5-day average traded value.<BR><BR>In summary, while Nukleus Office has shown some positive price movements recently, the combination of underperformance against its sector today, erratic trading patterns, and declining investor participation may contribute to a cautious outlook for the stock.